Detail Information of Epigenetic Regulations

General Information of Drug Transporter (DT)
DT ID	DTD0265 Transporter Info
Gene Name	SLC2A7
Transporter Name	Glucose transporter type 7
Gene ID	155184
UniProt ID	Q6PXP3

Epigenetic Regulations of This DT (EGR)
Methylation
Pancretic ductal adenocarcinoma	10 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Methylation of SLC2A7 in pancretic ductal adenocarcinoma			[ 1 ]
Location	5'UTR (cg00953201)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.42E+00	Statistic Test	p-value:2.19E-07; Z-score:1.88E+00
Methylation in Case	8.42E-01 (Median)	Methylation in Control	5.92E-01 (Median)
Studied Phenotype	Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon2	Methylation of SLC2A7 in pancretic ductal adenocarcinoma			[ 1 ]
Location	TSS1500 (cg25804018)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.27E+00	Statistic Test	p-value:3.44E-12; Z-score:1.16E+00
Methylation in Case	1.51E-01 (Median)	Methylation in Control	1.18E-01 (Median)
Studied Phenotype	Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon3	Methylation of SLC2A7 in pancretic ductal adenocarcinoma			[ 1 ]
Location	TSS1500 (cg26062856)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.18E+00	Statistic Test	p-value:6.13E-05; Z-score:1.18E+00
Methylation in Case	5.97E-01 (Median)	Methylation in Control	5.06E-01 (Median)
Studied Phenotype	Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon4	Methylation of SLC2A7 in pancretic ductal adenocarcinoma			[ 1 ]
Location	TSS200 (cg26757305)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.19E+00	Statistic Test	p-value:2.36E-03; Z-score:-6.33E-01
Methylation in Case	1.02E-01 (Median)	Methylation in Control	1.22E-01 (Median)
Studied Phenotype	Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon5	Methylation of SLC2A7 in pancretic ductal adenocarcinoma			[ 1 ]
Location	TSS200 (cg10196861)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.08E+00	Statistic Test	p-value:5.67E-03; Z-score:-5.76E-01
Methylation in Case	4.81E-02 (Median)	Methylation in Control	5.19E-02 (Median)
Studied Phenotype	Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon6	Methylation of SLC2A7 in pancretic ductal adenocarcinoma			[ 1 ]
Location	Body (cg07339236)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-3.61E+00	Statistic Test	p-value:1.14E-16; Z-score:-3.36E+00
Methylation in Case	1.55E-01 (Median)	Methylation in Control	5.59E-01 (Median)
Studied Phenotype	Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon7	Methylation of SLC2A7 in pancretic ductal adenocarcinoma			[ 1 ]
Location	Body (cg01829829)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.06E+00	Statistic Test	p-value:1.76E-10; Z-score:-1.13E+00
Methylation in Case	7.24E-01 (Median)	Methylation in Control	7.67E-01 (Median)
Studied Phenotype	Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon8	Methylation of SLC2A7 in pancretic ductal adenocarcinoma			[ 1 ]
Location	Body (cg04792642)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.03E+00	Statistic Test	p-value:7.24E-03; Z-score:6.32E-01
Methylation in Case	6.03E-01 (Median)	Methylation in Control	5.84E-01 (Median)
Studied Phenotype	Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon9	Methylation of SLC2A7 in pancretic ductal adenocarcinoma			[ 1 ]
Location	Body (cg11185804)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.03E+00	Statistic Test	p-value:2.04E-02; Z-score:9.86E-01
Methylation in Case	8.55E-01 (Median)	Methylation in Control	8.30E-01 (Median)
Studied Phenotype	Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon10	Methylation of SLC2A7 in pancretic ductal adenocarcinoma			[ 1 ]
Location	3'UTR (cg11804721)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.13E+00	Statistic Test	p-value:5.27E-04; Z-score:6.24E-01
Methylation in Case	4.73E-01 (Median)	Methylation in Control	4.19E-01 (Median)
Studied Phenotype	Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]
Experimental Material	Patient tissue samples
Bladder cancer	9 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Methylation of SLC2A7 in bladder cancer			[ 2 ]
Location	TSS1500 (cg00648005)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.41E+00	Statistic Test	p-value:1.33E-09; Z-score:-1.16E+01
Methylation in Case	4.57E-01 (Median)	Methylation in Control	6.44E-01 (Median)
Studied Phenotype	Bladder cancer[ ICD-11:2C94]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon2	Methylation of SLC2A7 in bladder cancer			[ 2 ]
Location	TSS1500 (cg24027679)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.06E+00	Statistic Test	p-value:7.85E-03; Z-score:-2.57E+00
Methylation in Case	7.33E-01 (Median)	Methylation in Control	7.78E-01 (Median)
Studied Phenotype	Bladder cancer[ ICD-11:2C94]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon3	Methylation of SLC2A7 in bladder cancer			[ 2 ]
Location	TSS1500 (cg03886254)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.01E+00	Statistic Test	p-value:4.18E-02; Z-score:1.88E+00
Methylation in Case	9.24E-01 (Median)	Methylation in Control	9.15E-01 (Median)
Studied Phenotype	Bladder cancer[ ICD-11:2C94]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon4	Methylation of SLC2A7 in bladder cancer			[ 2 ]
Location	TSS200 (cg04599612)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.33E+00	Statistic Test	p-value:3.43E-08; Z-score:-8.58E+00
Methylation in Case	5.18E-01 (Median)	Methylation in Control	6.89E-01 (Median)
Studied Phenotype	Bladder cancer[ ICD-11:2C94]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon5	Methylation of SLC2A7 in bladder cancer			[ 2 ]
Location	Body (cg03216475)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.19E+00	Statistic Test	p-value:1.29E-05; Z-score:-4.25E+00
Methylation in Case	6.57E-01 (Median)	Methylation in Control	7.84E-01 (Median)
Studied Phenotype	Bladder cancer[ ICD-11:2C94]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon6	Methylation of SLC2A7 in bladder cancer			[ 2 ]
Location	Body (cg07343511)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.29E+00	Statistic Test	p-value:5.71E-05; Z-score:4.78E+00
Methylation in Case	7.60E-01 (Median)	Methylation in Control	5.90E-01 (Median)
Studied Phenotype	Bladder cancer[ ICD-11:2C94]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon7	Methylation of SLC2A7 in bladder cancer			[ 2 ]
Location	Body (cg16084788)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.03E+00	Statistic Test	p-value:6.05E-03; Z-score:-4.42E+00
Methylation in Case	8.50E-01 (Median)	Methylation in Control	8.77E-01 (Median)
Studied Phenotype	Bladder cancer[ ICD-11:2C94]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon8	Methylation of SLC2A7 in bladder cancer			[ 2 ]
Location	Body (cg20822540)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.14E+00	Statistic Test	p-value:1.32E-02; Z-score:-1.61E+00
Methylation in Case	6.32E-01 (Median)	Methylation in Control	7.24E-01 (Median)
Studied Phenotype	Bladder cancer[ ICD-11:2C94]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon9	Methylation of SLC2A7 in bladder cancer			[ 2 ]
Location	Body (cg04437482)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.21E+00	Statistic Test	p-value:1.41E-02; Z-score:-3.26E+00
Methylation in Case	5.04E-01 (Median)	Methylation in Control	6.08E-01 (Median)
Studied Phenotype	Bladder cancer[ ICD-11:2C94]
Experimental Material	Patient tissue samples
Breast cancer	12 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Methylation of SLC2A7 in breast cancer			[ 3 ]
Location	TSS1500 (cg24027679)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.13E+00	Statistic Test	p-value:3.85E-07; Z-score:-1.91E+00
Methylation in Case	6.92E-01 (Median)	Methylation in Control	7.81E-01 (Median)
Studied Phenotype	Breast cancer[ ICD-11:2C60-2C6Z]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon2	Methylation of SLC2A7 in breast cancer			[ 3 ]
Location	TSS1500 (cg00648005)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.09E+00	Statistic Test	p-value:2.13E-06; Z-score:-1.12E+00
Methylation in Case	5.87E-01 (Median)	Methylation in Control	6.37E-01 (Median)
Studied Phenotype	Breast cancer[ ICD-11:2C60-2C6Z]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon3	Methylation of SLC2A7 in breast cancer			[ 3 ]
Location	TSS1500 (cg03886254)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.02E+00	Statistic Test	p-value:4.36E-02; Z-score:-4.86E-01
Methylation in Case	8.94E-01 (Median)	Methylation in Control	9.12E-01 (Median)
Studied Phenotype	Breast cancer[ ICD-11:2C60-2C6Z]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon4	Methylation of SLC2A7 in breast cancer			[ 3 ]
Location	TSS200 (cg04599612)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.23E+00	Statistic Test	p-value:4.75E-19; Z-score:-3.63E+00
Methylation in Case	6.12E-01 (Median)	Methylation in Control	7.51E-01 (Median)
Studied Phenotype	Breast cancer[ ICD-11:2C60-2C6Z]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon5	Methylation of SLC2A7 in breast cancer			[ 3 ]
Location	TSS200 (cg09121478)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.01E+00	Statistic Test	p-value:9.96E-04; Z-score:-5.60E-01
Methylation in Case	7.90E-01 (Median)	Methylation in Control	8.01E-01 (Median)
Studied Phenotype	Breast cancer[ ICD-11:2C60-2C6Z]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon6	Methylation of SLC2A7 in breast cancer			[ 3 ]
Location	Body (cg04437482)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.17E+00	Statistic Test	p-value:5.43E-12; Z-score:-2.87E+00
Methylation in Case	5.48E-01 (Median)	Methylation in Control	6.42E-01 (Median)
Studied Phenotype	Breast cancer[ ICD-11:2C60-2C6Z]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon7	Methylation of SLC2A7 in breast cancer			[ 3 ]
Location	Body (cg16084788)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.07E+00	Statistic Test	p-value:4.60E-06; Z-score:-1.36E+00
Methylation in Case	8.15E-01 (Median)	Methylation in Control	8.70E-01 (Median)
Studied Phenotype	Breast cancer[ ICD-11:2C60-2C6Z]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon8	Methylation of SLC2A7 in breast cancer			[ 3 ]
Location	Body (cg03216475)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.21E+00	Statistic Test	p-value:5.58E-05; Z-score:-9.58E-01
Methylation in Case	6.33E-01 (Median)	Methylation in Control	7.64E-01 (Median)
Studied Phenotype	Breast cancer[ ICD-11:2C60-2C6Z]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon9	Methylation of SLC2A7 in breast cancer			[ 3 ]
Location	Body (cg00087511)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.02E+00	Statistic Test	p-value:3.51E-03; Z-score:-4.44E-01
Methylation in Case	7.91E-01 (Median)	Methylation in Control	8.04E-01 (Median)
Studied Phenotype	Breast cancer[ ICD-11:2C60-2C6Z]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon10	Methylation of SLC2A7 in breast cancer			[ 3 ]
Location	Body (cg20822540)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.05E+00	Statistic Test	p-value:1.09E-02; Z-score:-5.47E-01
Methylation in Case	7.23E-01 (Median)	Methylation in Control	7.56E-01 (Median)
Studied Phenotype	Breast cancer[ ICD-11:2C60-2C6Z]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon11	Methylation of SLC2A7 in breast cancer			[ 3 ]
Location	Body (cg21807930)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.04E+00	Statistic Test	p-value:1.86E-02; Z-score:-5.03E-01
Methylation in Case	8.85E-01 (Median)	Methylation in Control	9.17E-01 (Median)
Studied Phenotype	Breast cancer[ ICD-11:2C60-2C6Z]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon12	Methylation of SLC2A7 in breast cancer			[ 3 ]
Location	Body (cg07343511)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.08E+00	Statistic Test	p-value:2.19E-02; Z-score:9.63E-01
Methylation in Case	7.06E-01 (Median)	Methylation in Control	6.52E-01 (Median)
Studied Phenotype	Breast cancer[ ICD-11:2C60-2C6Z]
Experimental Material	Patient tissue samples
Celiac disease	1 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Methylation of SLC2A7 in celiac disease			[ 4 ]
Location	TSS1500 (cg03886254)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.82E+00	Statistic Test	p-value:2.07E-02; Z-score:1.31E+00
Methylation in Case	8.62E-01 (Median)	Methylation in Control	4.74E-01 (Median)
Studied Phenotype	Celiac disease[ ICD-11:DA95]
Experimental Material	Patient tissue samples
Colorectal cancer	8 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Methylation of SLC2A7 in colorectal cancer			[ 5 ]
Location	TSS1500 (cg00648005)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.28E+00	Statistic Test	p-value:6.09E-05; Z-score:-1.27E+00
Methylation in Case	4.69E-01 (Median)	Methylation in Control	6.01E-01 (Median)
Studied Phenotype	Colorectal cancer[ ICD-11:2B91]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon2	Methylation of SLC2A7 in colorectal cancer			[ 5 ]
Location	Body (cg04437482)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.11E+00	Statistic Test	p-value:6.94E-11; Z-score:-4.44E+00
Methylation in Case	7.95E-01 (Median)	Methylation in Control	8.84E-01 (Median)
Studied Phenotype	Colorectal cancer[ ICD-11:2B91]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon3	Methylation of SLC2A7 in colorectal cancer			[ 5 ]
Location	Body (cg20822540)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.12E+00	Statistic Test	p-value:9.02E-07; Z-score:-1.54E+00
Methylation in Case	7.25E-01 (Median)	Methylation in Control	8.16E-01 (Median)
Studied Phenotype	Colorectal cancer[ ICD-11:2B91]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon4	Methylation of SLC2A7 in colorectal cancer			[ 5 ]
Location	Body (cg21807930)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.01E+00	Statistic Test	p-value:3.00E-05; Z-score:-1.08E+00
Methylation in Case	9.30E-01 (Median)	Methylation in Control	9.42E-01 (Median)
Studied Phenotype	Colorectal cancer[ ICD-11:2B91]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon5	Methylation of SLC2A7 in colorectal cancer			[ 5 ]
Location	Body (cg00087511)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.07E+00	Statistic Test	p-value:7.72E-05; Z-score:-1.37E+00
Methylation in Case	8.08E-01 (Median)	Methylation in Control	8.61E-01 (Median)
Studied Phenotype	Colorectal cancer[ ICD-11:2B91]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon6	Methylation of SLC2A7 in colorectal cancer			[ 5 ]
Location	Body (cg03216475)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.04E+00	Statistic Test	p-value:1.90E-04; Z-score:-9.01E-01
Methylation in Case	7.41E-01 (Median)	Methylation in Control	7.70E-01 (Median)
Studied Phenotype	Colorectal cancer[ ICD-11:2B91]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon7	Methylation of SLC2A7 in colorectal cancer			[ 5 ]
Location	Body (cg17032590)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.01E+00	Statistic Test	p-value:1.53E-02; Z-score:-2.95E-01
Methylation in Case	9.15E-01 (Median)	Methylation in Control	9.21E-01 (Median)
Studied Phenotype	Colorectal cancer[ ICD-11:2B91]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon8	Methylation of SLC2A7 in colorectal cancer			[ 5 ]
Location	Body (cg16084788)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.01E+00	Statistic Test	p-value:1.90E-02; Z-score:-7.09E-01
Methylation in Case	9.37E-01 (Median)	Methylation in Control	9.43E-01 (Median)
Studied Phenotype	Colorectal cancer[ ICD-11:2B91]
Experimental Material	Patient tissue samples
Hepatocellular carcinoma	13 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Methylation of SLC2A7 in hepatocellular carcinoma			[ 6 ]
Location	TSS1500 (cg24027679)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.11E+00	Statistic Test	p-value:1.64E-07; Z-score:-2.33E+00
Methylation in Case	6.65E-01 (Median)	Methylation in Control	7.39E-01 (Median)
Studied Phenotype	Hepatocellular carcinoma[ ICD-11:2C12.02]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon2	Methylation of SLC2A7 in hepatocellular carcinoma			[ 6 ]
Location	TSS1500 (cg00648005)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.08E+00	Statistic Test	p-value:1.90E-06; Z-score:-1.16E+00
Methylation in Case	6.45E-01 (Median)	Methylation in Control	6.96E-01 (Median)
Studied Phenotype	Hepatocellular carcinoma[ ICD-11:2C12.02]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon3	Methylation of SLC2A7 in hepatocellular carcinoma			[ 6 ]
Location	TSS200 (cg04599612)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.12E+00	Statistic Test	p-value:2.12E-06; Z-score:-1.69E+00
Methylation in Case	5.83E-01 (Median)	Methylation in Control	6.52E-01 (Median)
Studied Phenotype	Hepatocellular carcinoma[ ICD-11:2C12.02]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon4	Methylation of SLC2A7 in hepatocellular carcinoma			[ 6 ]
Location	Body (cg04408162)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.49E+00	Statistic Test	p-value:2.51E-18; Z-score:-3.72E+00
Methylation in Case	1.81E-01 (Median)	Methylation in Control	2.70E-01 (Median)
Studied Phenotype	Hepatocellular carcinoma[ ICD-11:2C12.02]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon5	Methylation of SLC2A7 in hepatocellular carcinoma			[ 6 ]
Location	Body (cg23274660)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.67E+00	Statistic Test	p-value:2.21E-16; Z-score:-1.95E+00
Methylation in Case	1.88E-01 (Median)	Methylation in Control	3.14E-01 (Median)
Studied Phenotype	Hepatocellular carcinoma[ ICD-11:2C12.02]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon6	Methylation of SLC2A7 in hepatocellular carcinoma			[ 6 ]
Location	Body (cg11376147)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.28E+00	Statistic Test	p-value:1.97E-13; Z-score:-1.57E+00
Methylation in Case	1.86E-01 (Median)	Methylation in Control	2.37E-01 (Median)
Studied Phenotype	Hepatocellular carcinoma[ ICD-11:2C12.02]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon7	Methylation of SLC2A7 in hepatocellular carcinoma			[ 6 ]
Location	Body (cg17032590)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.07E+00	Statistic Test	p-value:2.07E-07; Z-score:-2.39E+00
Methylation in Case	7.55E-01 (Median)	Methylation in Control	8.06E-01 (Median)
Studied Phenotype	Hepatocellular carcinoma[ ICD-11:2C12.02]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon8	Methylation of SLC2A7 in hepatocellular carcinoma			[ 6 ]
Location	Body (cg21807930)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.03E+00	Statistic Test	p-value:9.17E-06; Z-score:-9.68E-01
Methylation in Case	9.03E-01 (Median)	Methylation in Control	9.27E-01 (Median)
Studied Phenotype	Hepatocellular carcinoma[ ICD-11:2C12.02]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon9	Methylation of SLC2A7 in hepatocellular carcinoma			[ 6 ]
Location	Body (cg26529484)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.01E+00	Statistic Test	p-value:5.32E-04; Z-score:-5.45E-01
Methylation in Case	9.57E-01 (Median)	Methylation in Control	9.65E-01 (Median)
Studied Phenotype	Hepatocellular carcinoma[ ICD-11:2C12.02]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon10	Methylation of SLC2A7 in hepatocellular carcinoma			[ 6 ]
Location	Body (cg16084788)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.00E+00	Statistic Test	p-value:1.19E-02; Z-score:1.21E-01
Methylation in Case	8.50E-01 (Median)	Methylation in Control	8.47E-01 (Median)
Studied Phenotype	Hepatocellular carcinoma[ ICD-11:2C12.02]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon11	Methylation of SLC2A7 in hepatocellular carcinoma			[ 6 ]
Location	Body (cg20822540)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.01E+00	Statistic Test	p-value:1.69E-02; Z-score:-1.98E-01
Methylation in Case	7.08E-01 (Median)	Methylation in Control	7.17E-01 (Median)
Studied Phenotype	Hepatocellular carcinoma[ ICD-11:2C12.02]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon12	Methylation of SLC2A7 in hepatocellular carcinoma			[ 6 ]
Location	Body (cg07343511)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.01E+00	Statistic Test	p-value:3.59E-02; Z-score:-1.69E-01
Methylation in Case	7.73E-01 (Median)	Methylation in Control	7.80E-01 (Median)
Studied Phenotype	Hepatocellular carcinoma[ ICD-11:2C12.02]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon13	Methylation of SLC2A7 in hepatocellular carcinoma			[ 6 ]
Location	3'UTR (cg24020826)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-2.34E+00	Statistic Test	p-value:5.31E-26; Z-score:-5.97E+00
Methylation in Case	2.65E-01 (Median)	Methylation in Control	6.20E-01 (Median)
Studied Phenotype	Hepatocellular carcinoma[ ICD-11:2C12.02]
Experimental Material	Patient tissue samples
HIV infection	6 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Methylation of SLC2A7 in HIV infection			[ 7 ]
Location	TSS1500 (cg00648005)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.14E+00	Statistic Test	p-value:5.18E-08; Z-score:1.94E+00
Methylation in Case	6.66E-01 (Median)	Methylation in Control	5.83E-01 (Median)
Studied Phenotype	HIV infection[ ICD-11:1C62.Z]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon2	Methylation of SLC2A7 in HIV infection			[ 7 ]
Location	TSS1500 (cg24027679)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.02E+00	Statistic Test	p-value:8.57E-03; Z-score:-6.61E-01
Methylation in Case	8.31E-01 (Median)	Methylation in Control	8.52E-01 (Median)
Studied Phenotype	HIV infection[ ICD-11:1C62.Z]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon3	Methylation of SLC2A7 in HIV infection			[ 7 ]
Location	TSS200 (cg04599612)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.07E+00	Statistic Test	p-value:1.22E-02; Z-score:-1.27E+00
Methylation in Case	6.68E-01 (Median)	Methylation in Control	7.16E-01 (Median)
Studied Phenotype	HIV infection[ ICD-11:1C62.Z]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon4	Methylation of SLC2A7 in HIV infection			[ 7 ]
Location	Body (cg16084788)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.03E+00	Statistic Test	p-value:6.35E-06; Z-score:-1.55E+00
Methylation in Case	8.91E-01 (Median)	Methylation in Control	9.21E-01 (Median)
Studied Phenotype	HIV infection[ ICD-11:1C62.Z]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon5	Methylation of SLC2A7 in HIV infection			[ 7 ]
Location	Body (cg07343511)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.03E+00	Statistic Test	p-value:1.16E-04; Z-score:1.20E+00
Methylation in Case	8.73E-01 (Median)	Methylation in Control	8.45E-01 (Median)
Studied Phenotype	HIV infection[ ICD-11:1C62.Z]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon6	Methylation of SLC2A7 in HIV infection			[ 7 ]
Location	Body (cg03216475)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.03E+00	Statistic Test	p-value:3.56E-02; Z-score:-9.65E-01
Methylation in Case	7.87E-01 (Median)	Methylation in Control	8.13E-01 (Median)
Studied Phenotype	HIV infection[ ICD-11:1C62.Z]
Experimental Material	Patient tissue samples
Papillary thyroid cancer	8 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Methylation of SLC2A7 in papillary thyroid cancer			[ 8 ]
Location	TSS1500 (cg24027679)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.02E+00	Statistic Test	p-value:1.39E-02; Z-score:-5.94E-01
Methylation in Case	8.52E-01 (Median)	Methylation in Control	8.71E-01 (Median)
Studied Phenotype	Papillary thyroid cancer[ ICD-11:2D10.1]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon2	Methylation of SLC2A7 in papillary thyroid cancer			[ 8 ]
Location	TSS200 (cg09121478)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.02E+00	Statistic Test	p-value:5.02E-07; Z-score:-1.04E+00
Methylation in Case	8.71E-01 (Median)	Methylation in Control	8.91E-01 (Median)
Studied Phenotype	Papillary thyroid cancer[ ICD-11:2D10.1]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon3	Methylation of SLC2A7 in papillary thyroid cancer			[ 8 ]
Location	TSS200 (cg04599612)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.08E+00	Statistic Test	p-value:8.65E-07; Z-score:-1.49E+00
Methylation in Case	7.37E-01 (Median)	Methylation in Control	7.96E-01 (Median)
Studied Phenotype	Papillary thyroid cancer[ ICD-11:2D10.1]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon4	Methylation of SLC2A7 in papillary thyroid cancer			[ 8 ]
Location	Body (cg03216475)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.05E+00	Statistic Test	p-value:1.10E-05; Z-score:-9.51E-01
Methylation in Case	6.95E-01 (Median)	Methylation in Control	7.29E-01 (Median)
Studied Phenotype	Papillary thyroid cancer[ ICD-11:2D10.1]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon5	Methylation of SLC2A7 in papillary thyroid cancer			[ 8 ]
Location	Body (cg07343511)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.08E+00	Statistic Test	p-value:9.01E-05; Z-score:1.51E+00
Methylation in Case	7.69E-01 (Median)	Methylation in Control	7.13E-01 (Median)
Studied Phenotype	Papillary thyroid cancer[ ICD-11:2D10.1]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon6	Methylation of SLC2A7 in papillary thyroid cancer			[ 8 ]
Location	Body (cg00087511)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.02E+00	Statistic Test	p-value:1.55E-04; Z-score:-9.43E-01
Methylation in Case	8.63E-01 (Median)	Methylation in Control	8.85E-01 (Median)
Studied Phenotype	Papillary thyroid cancer[ ICD-11:2D10.1]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon7	Methylation of SLC2A7 in papillary thyroid cancer			[ 8 ]
Location	Body (cg16084788)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.01E+00	Statistic Test	p-value:6.56E-03; Z-score:-5.65E-01
Methylation in Case	9.33E-01 (Median)	Methylation in Control	9.41E-01 (Median)
Studied Phenotype	Papillary thyroid cancer[ ICD-11:2D10.1]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon8	Methylation of SLC2A7 in papillary thyroid cancer			[ 8 ]
Location	Body (cg21807930)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.00E+00	Statistic Test	p-value:4.71E-02; Z-score:-1.74E-01
Methylation in Case	8.82E-01 (Median)	Methylation in Control	8.85E-01 (Median)
Studied Phenotype	Papillary thyroid cancer[ ICD-11:2D10.1]
Experimental Material	Patient tissue samples
Prostate cancer	2 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Methylation of SLC2A7 in prostate cancer			[ 9 ]
Location	TSS1500 (cg00755448)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:4.01E+00	Statistic Test	p-value:1.66E-02; Z-score:5.91E+01
Methylation in Case	3.61E-01 (Median)	Methylation in Control	8.99E-02 (Median)
Studied Phenotype	Prostate cancer[ ICD-11:2C82]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon2	Methylation of SLC2A7 in prostate cancer			[ 9 ]
Location	TSS200 (cg04332235)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.69E+00	Statistic Test	p-value:4.68E-03; Z-score:1.41E+01
Methylation in Case	9.31E-02 (Median)	Methylation in Control	5.50E-02 (Median)
Studied Phenotype	Prostate cancer[ ICD-11:2C82]
Experimental Material	Patient tissue samples
Lung adenocarcinoma	4 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Methylation of SLC2A7 in lung adenocarcinoma			[ 10 ]
Location	TSS200 (cg04599612)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.10E+00	Statistic Test	p-value:1.72E-02; Z-score:-1.94E+00
Methylation in Case	6.68E-01 (Median)	Methylation in Control	7.32E-01 (Median)
Studied Phenotype	Lung adenocarcinoma[ ICD-11:2C25.0]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon2	Methylation of SLC2A7 in lung adenocarcinoma			[ 10 ]
Location	Body (cg07343511)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.14E+00	Statistic Test	p-value:1.19E-03; Z-score:1.83E+00
Methylation in Case	7.97E-01 (Median)	Methylation in Control	6.97E-01 (Median)
Studied Phenotype	Lung adenocarcinoma[ ICD-11:2C25.0]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon3	Methylation of SLC2A7 in lung adenocarcinoma			[ 10 ]
Location	Body (cg03216475)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.08E+00	Statistic Test	p-value:3.95E-03; Z-score:-1.87E+00
Methylation in Case	7.35E-01 (Median)	Methylation in Control	7.91E-01 (Median)
Studied Phenotype	Lung adenocarcinoma[ ICD-11:2C25.0]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon4	Methylation of SLC2A7 in lung adenocarcinoma			[ 10 ]
Location	Body (cg00087511)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.08E+00	Statistic Test	p-value:6.94E-03; Z-score:-3.62E+00
Methylation in Case	7.95E-01 (Median)	Methylation in Control	8.56E-01 (Median)
Studied Phenotype	Lung adenocarcinoma[ ICD-11:2C25.0]
Experimental Material	Patient tissue samples
Atypical teratoid rhabdoid tumor	4 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Methylation of SLC2A7 in atypical teratoid rhabdoid tumor			[ 11 ]
Location	Body (cg00087511)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.01E+00	Statistic Test	p-value:1.64E-05; Z-score:-6.40E-01
Methylation in Case	9.68E-01 (Median)	Methylation in Control	9.74E-01 (Median)
Studied Phenotype	Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon2	Methylation of SLC2A7 in atypical teratoid rhabdoid tumor			[ 11 ]
Location	Body (cg03216475)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-2.12E+00	Statistic Test	p-value:2.67E-04; Z-score:-7.00E-01
Methylation in Case	9.10E-02 (Median)	Methylation in Control	1.93E-01 (Median)
Studied Phenotype	Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon3	Methylation of SLC2A7 in atypical teratoid rhabdoid tumor			[ 11 ]
Location	Body (cg04437482)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.03E+00	Statistic Test	p-value:7.74E-04; Z-score:-5.89E-01
Methylation in Case	8.87E-01 (Median)	Methylation in Control	9.17E-01 (Median)
Studied Phenotype	Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon4	Methylation of SLC2A7 in atypical teratoid rhabdoid tumor			[ 11 ]
Location	Body (cg07343511)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.03E+00	Statistic Test	p-value:3.81E-03; Z-score:-5.12E-01
Methylation in Case	8.37E-01 (Median)	Methylation in Control	8.66E-01 (Median)
Studied Phenotype	Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y]
Experimental Material	Patient tissue samples
Depression	1 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Methylation of SLC2A7 in depression			[ 12 ]
Location	Body (cg07343511)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.01E+00	Statistic Test	p-value:3.31E-02; Z-score:6.03E-01
Methylation in Case	7.69E-01 (Median)	Methylation in Control	7.58E-01 (Median)
Studied Phenotype	Depression[ ICD-11:6A8Z]
Experimental Material	Patient tissue samples
Panic disorder	1 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Methylation of SLC2A7 in panic disorder			[ 13 ]
Location	Body (cg03216475)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.09E+00	Statistic Test	p-value:1.76E-02; Z-score:5.51E-01
Methylation in Case	2.64E+00 (Median)	Methylation in Control	2.43E+00 (Median)
Studied Phenotype	Panic disorder[ ICD-11:6B01]
Experimental Material	Patient tissue samples
Systemic lupus erythematosus	1 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Methylation of SLC2A7 in systemic lupus erythematosus			[ 14 ]
Location	Body (cg17032590)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.01E+00	Statistic Test	p-value:4.09E-02; Z-score:-1.58E-01
Methylation in Case	8.70E-01 (Median)	Methylation in Control	8.75E-01 (Median)
Studied Phenotype	Systemic lupus erythematosus[ ICD-11:4A40.0]
Experimental Material	Patient tissue samples

References
1	Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling. Int J Cancer. 2014 Sep 1;135(5):1110-8.
2	DNA Methylation Dynamics in Urological Tumors.
3	Genome-wide Scan for Methylation Profiles in Breast Cancer
4	The methylome of the celiac intestinal epithelium harbours genotype-independent alterations in the HLA region. Mol Ther Oncolytics. 2019 Feb 5;12:235-245.
5	Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer. Gastroenterology. 2014 Aug;147(2):418-29.e8.
6	Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips. Epigenetics. 2013 Jan;8(1):34-43.
7	HIV-1 Infection Accelerates Age According to the Epigenetic Clock. J Infect Dis. 2015 Nov 15;212(10):1563-73.
8	Prognostic Classifier Based on Genome-Wide DNA Methylation Profiling in Well-Differentiated Thyroid Tumors. J Clin Endocrinol Metab. 2017 Nov 1;102(11):4089-4099.
9	Reducing the risk of false discovery enabling identification of biologically significant genome-wide methylation status using the HumanMethylation450 array. BMC Genomics. 2014 Jan 22;15:51.
10	DNA methylation analysis of lung adenocarcinoma and adjacent non-tumor tissues
11	Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes. Cancer Cell. 2016 Mar 14;29(3):379-393.
12	DNA methylation and inflammation marker profiles associated with a history of depression. Hum Mol Genet. 2018 Aug 15;27(16):2840-2850.
13	DNA Methylation signatures in panic disorder. Transl Psychiatry. 2017 Dec 18;7(12):1287.
14	Genome-wide DNA methylation analysis of systemic lupus erythematosus reveals persistent hypomethylation of interferon genes and compositional changes to CD4+ T-cell populations. PLoS Genet. 2013;9(8):e1003678.

If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.

Detail Information of Epigenetic Regulations

Visitor Map

Correspondence